The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia

Frontiers in Pharmacology
Chao-Yang WangXue-Qun Ren

Abstract

Background: In recent decades, research on drug therapy for ventilator-associated pneumonia (VAP) remains one of the major hot-spots in the field of critical care medicine, but relevant data are not satisfactory. Our aim was to assess the status and trends of the most cited articles on drug therapy for VAP through bibliometric approaches. Methods: The Institute for Scientific Information (ISI) Web of Science core collection database was searched for the VAP-related articles. The time period for retrieval was from the beginning of the database to September 30, 2018. The top 100 most cited articles were selected to obtain their information on the authors, title, publication, number of citations, author's affiliations, country, etc. These general information and bibliometric data were collected for analysis. VOSviewer software was used to generate a term co-occurrence graph that visualized a reference pattern for different terms in the 100 articles. Results: The number of citations for the 100 selected articles ranged from 142 to 3,218. These articles were published in 31 different journals. The top three journals in terms of the number of our selected articles they published were "Critical Care Medicine" (17 articles), "American ...Continue Reading

References

Jul 11, 2000·Archives of Internal Medicine·R S Morehead, S J Pinto
Jun 1, 2002·JAMA : the Journal of the American Medical Association·Michael CallahamEllen Weber
May 10, 2003·American Journal of Respiratory and Critical Care Medicine·Muriel FartoukhChristian Brun-Buisson
Apr 11, 2006·American Journal of Respiratory and Critical Care Medicine·Mirelle KoemanMarc J M Bonten
Oct 26, 2007·The European Respiratory Journal·P RamirezA Torres
Mar 25, 2008·Journal of Critical Care·John MuscedereUNKNOWN VAP Guidelines Committee and the Canadian Critical Care Trials Group
Dec 3, 2009·JAMA : the Journal of the American Medical Association·Jean-Louis VincentUNKNOWN EPIC II Group of Investigators
Dec 18, 2009·Expert Review of Anti-infective Therapy·Alexandre P ZavasckiAna C Gales
Mar 23, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Marcos I RestrepoMarin H Kollef
Jun 30, 2010·Scientometrics·Nees Jan van Eck, Ludo Waltman
Mar 26, 2013·Current Opinion in Pulmonary Medicine·François BarbierLila Bouadma
Apr 9, 2013·Revista Da Sociedade Brasileira De Medicina Tropical·Michel Rodrigues MoreiraPaulo Pinto Gontijo Filho
Feb 14, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Veronique NussenblattSara E Cosgrove
Nov 19, 2014·Critical Care : the Official Journal of the Critical Care Forum·Charles-Edouard LuytJean Chastre
Sep 1, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christian E Sandrock, Andrew F Shorr
Nov 3, 2015·Expert Review of Respiratory Medicine·Haseeb Munaf SeriwalaSyed Raza Shah
Apr 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tamar F BarlamKavita K Trivedi
Jul 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andre C KalilJan L Brozek
Aug 24, 2016·International Journal of Cardiology·Jiangquan LiaoYan Dong
Jul 14, 2018·Indian Journal of Pathology & Microbiology·Somi PatroNirupama Chayani

❮ Previous
Next ❯

Software Mentioned

Excel
VOSviewer

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.